SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Frostman who wrote (3332)12/10/1997 6:29:00 PM
From: Evan Dimmer  Read Replies (2) | Respond to of 23519
 
This could be good unexpected news then right? Did I miss that, where did you get that from?

Ed



To: Frostman who wrote (3332)12/10/1997 9:55:00 PM
From: Andreas Samson  Read Replies (1) | Respond to of 23519
 
Frosty, VVUS knows it's booked the $2M UK order. If VVUS is publically committing to a 25% sequential revenue decline, then alas, that's what it's gonna be.

>>They have one $2 million mile-stone for the UK deal within Q4 which will be roughly 6 cents a share
gross. This is above and beyond production revenue. I do not believe estimates for Q4 reflected this
payment.<<


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News